⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VIVS News
VivoSim Labs, Inc. Common Stock
Form 8-K
sec.gov
VIVS
Form 8-K
sec.gov
VIVS
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
globenewswire.com
VIVS
Form 8-K
sec.gov
VIVS
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
globenewswire.com
VIVS
Three Biotechs Deliver Catalysts to Watch
globenewswire.com
NTHI
ERNA
VIVS
LLY
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
globenewswire.com
VIVS
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
globenewswire.com
VIVS
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
globenewswire.com
VIVS
Digital Biomarkers Market worth $17.73 billion by 2031 | MarketsandMarkets™
prnewswire.com
VIVS